The Prime Minister, Shri Narendra Modi has said that the approval for world’s first DNA based ‘ZyCov-D’ vaccine of Zydus Universe is a testimony to the innovative zeal of India’s scientists. 

In response to a tweet by CDSCO India Info, the Prime Minister said;
"India is fighting COVID-19 with full vigour. The approval for world’s first DNA based ‘ZyCov-D’ vaccine of @ZydusUniverse is a testimony to the innovative zeal of India’s scientists. A momentous feat indeed." Read More

In public interest it is necessary to establish more facilities to regulate the testing of COVID-19 vaccines for quick release of vaccine batches for prevention and treatment of COVID-19 infection. Considering this requirement, the Government of India has identified two Autonomous Institutes of the Department of Biotechnology (DBT).

National Institute of Animal Biotechnology (NIAB), Hyderabad and National Centre for Cell Science (NCCS), Pune, for upgradation as Central Drug Laboratories (CDLs). The funding support for the same was provided under the PM-CARES funds. The two facilities are expected to test approx. 60 batches of vaccines per month. Read More

Shri Mansukh Mandaviya, Union Minister for Health and Family Welfare chaired the event Aarogya Dhara- 2.0 to mark the completion of 2 Cr treatments under Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (AB-PMJAY).

With the completion of more than 2 crore hospital admissions landmark, treatments worth approximately Rs 25,000 crore have been provided through a growing network of 23,000 public and private empaneled hospitals to patients across 33 States/UTs in the country since the launch of the scheme on 23rd September 2018. Read More

Ayush Minister Shri SarbabandaSonowal on Monday said that the Morarji Desai National Institute of Yoga (MDNIY) has the potential to become the world’s best educational institution in the field of Yoga at par with the US’s Harvard University. He was addressing the students and the faculty of MDNIY on his maiden visit to the institute after taking charge as the Minister of Ayush.

“MDNIY can become the number one institute for students all over the world. We need to make global efforts for this. If the US can set up an institute like Harvard, why can't we?” Shri Sonowal said. Read More

Indian Council of Medical Research [ICMR], the apex body at the forefront of formulating COVID-19 testing protocols in India has achieved the milestone of conducting 50 crores tests on 18th August, 2021.

With average daily testing of more than 17 lakhs in the month of August, India has tested 50 crore samples across the country till date. India has achieved the milestone of the last ten crore tests in only 55 days. On 21st July 2021, India had tested 45 Crores COVID-19 samples, which reached 50 crores mark on 18th August, 2021. Read More

In a landmark achievement, nearly 88 lakh (88,13,919) doses have been administered under the Largest Vaccination Drive yesterday on the 16th of August 2021. Achievement showcases the trust placed by the people of India in the Government in its fight against the COVID-19 Pandemic.

With the administration of more than 88.13 lakh doses, the cumulative vaccination coverage has increased to 55.47Cr (55,47,30,609). This translates to 46% of all adult Indians receiving the first dose. 13% of all adult Indians have received both doses of vaccine and are protected against COVID-19. Read More

The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms. The trial was stopped in February 2021 due to lack of efficacy based on a planned interim analysis.

The formal conclusions from the trial, which was funded primarily by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, and by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. Read More

Zydus Pharmaceuticals Inc, USA (a 100% subsidiary of Cadila Healthcare Limited (Zydus Cadila), a leading innovation-driven, global healthcare provider, has signed a license and supply agreement with CHEMI SpA (“CHEMI”) of Italy, a subsidiary of Italfarmaco Group, to launch the generic equivalent of Sanofi Aventis’s branded product Lovenox® (Enoxaparin Sodium Injection) in seven dosage strengths in the United States (US). 

Under the agreement, CHEMI will manufacture and supply the Enoxaparin Sodium Injection which Zydus will commercialize in the US. CHEMI owns proprietary rights on a pharmaceutical product composed of Enoxaparin Sodium (Preservative Free) single-use pre-filled syringes. Read More

Chief Minister Mr. Vijay Rupani announced important decisions to provide relief to the industries, MSME Units, etc. of the state to overcome the adverse effect of the second wave of Covid-19.

The Chief Minister had earlier announced ‘Atmanirbhar Package’ of Rs.14,000-crore after the first wave of Covid-19, to boost the economy by reviving industry and trade. Under this packaged, 31,166 industrialists received benefits of Rs.407.72 crore under 14 schemes by Gujarat Industrial Development Corporation (GIDC). Read More

The Department of Pharmaceutics, DPSRU organized a webinar on Drug Solubilization using Hot Melt Extrusion on 20th August 2021. Dr. Nitin Swarnakar who is Scientist III Global Technical Marketing, Pharma Solution was invited as a guest speaker.

The webinar started with the brief introduction about the program and all the participants were addressed with the welcome message by Dr. Madhu Gupta. The Director of SPS, Dr. Harvinder Popli graced the occasion with her valuable presence and also addressed the participants and the faculty members with her ideas and thoughts about Drug Solubilization. Read More

On 18th August 2021, NIPER-Ahmedabad organized an orientation program for the students and researchers joining in the Academic year 2020-21. 

Our Respected Mr. Padmin Buch (Advisor-Corporate Strategy & IPR, Ex-MD - GITCO, BoA of Accuprec) was invited as an Honorable Guest. He delivered an interactive expert talk on IPR Basics Importance in Research to Commercialisation.

Meditation has been around for thousands of years, and its value in today's life plays an important role in stress management and healthy living. Mindfulness meditation in particular is proven to help reduce stress and anxiety, reduce blood pressure and risk of heart attack and stroke, minimize the chance of making mistakes, reduce loneliness, and improve cognitive function.

Accuprec has organized a Meditation workshop for the employees of the Accuprec. Gurutattva - Samarpan Meditation team was invited for the workshop. The Presenters were Niral Panchal, Dr. Khyati Simaria, Vrushabh Jhaveri. They have very well explained the information for the meditation and some Adhyatmik knowledge for Chakras, Aura and Energy.

In the midst of the COVID19, Accuprec has been successfully faced and received the extension of approval for DSIR and NABL certification to provide the ACCURATE & PRECISE results to our clients.